Search Results 121-130 of 1205 for ⚙[광고텔레:SEOGOT] 찌라시배포 해외선물솔루션홍보 상위노출대행 신용카드현금화하는법 010실명인증구입 슬롯커뮤니티홍보⚙

1. Colorectal Cancer - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

   EPCAM. MLH1. MSH2. MSH6. STK11. PMS2. For participants with monogenic risk, the GIRA report recommends referral to a genetic counselor.

2. A Study to Evaluate the Relationship of the Glucose Threshold for Insulin Secretion with Beta-cell Function - Mayo Clinic

   The purpose of this study is to determine if the set-point for fasting insulin secretion, and the subsequent response to hyperglycemia, is altered in people ...

3. A Study to See if MPI SPECT Phase Analysis Can Detect Varying Levels of Changes in Heart Rhythm Patterns - Mayo Clinic

   The purpose of this study is to determine if MPI SPECT phase analysis can detect varying degrees of abnormal heart rhythm between patients with normal coronary ...

4. Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma - Mayo Clinic

   The primary objective of the study is to evaluate the effect of 3 dose levels of MEDI9929 (AMG 157) on asthma exacerbations in adult subjects with inadequately ...

6. Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies - Mayo Clinic

   A surveillance of respiratory tract related adverse events in patients treated with Tyvaso® (treprostinil) Inhalation Solution versus other FDA approved ...

7. Long-Term Safety of PF-00547659 in Ulcerative Colitis - Mayo Clinic

   Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to evaluate ...

8. Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer - Mayo Clinic

   Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor ...

9. A Study of Oral LGH447 in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   The primary purpose of this dose escalation study is to estimate the maximum tolerated dose (MTD) and/or recommended dose for expansion (RDE) of LGH447 as a ...

10. Clinical Evaluation of a Transmit/Receive Head Coil for PET/MR Brain Studies

    An attenuation map of the T/R head coil will be developed and evaluated in phantom experiments followed by the patient studies. The repeatability of generating ...